ALLMedicine™ Acid Sphingomyelinase Deficiency Center
Research & Reviews 28 results
Orphanet Journal of Rare Diseases; McGovern MM, Wasserstein MP et. al.
May 12th, 2021 - Acid sphingomyelinase deficiency (ASMD) (also known as Niemann-Pick disease types A and B) is a rare and debilitating lysosomal storage disorder. This prospective, multi-center, multinational longitudinal study aimed to characterize the clinical f...
European Respiratory Review : an Official Journal of the ... Borie R, Crestani B et. al.
May 1st, 2021 - Lysosomes are intracellular organelles that are responsible for degrading and recycling macromolecules. Lysosomal storage diseases (LSDs) are a group of inherited diseases caused by mutations affecting genes that encode the function of the lysosom...
https://doi.org/10.1038/s41436-021-01156-3 10.1146/annurev-biochem-013118-111518 10.1016/j.ymgme.2016.12.008 10.1542/peds.2004-0887 10.1016/j.jpeds.2004.02.048 10.1016/j.beem.2014.08.004 10.1212/01.wnl.0000194208.08904.0c 10.1016/j.jpeds.2006.06.034 10.1016/j.ymgme.2016.05.001 10.1002/ajmg.a.35624 10.1038/gim.2013.4 10.1016/j.ymgme.2015.05.013 10.1007/s10545-017-0123-6 10.1148/radiol.2381041696 10.1183/09031936.05.00034805 10.1183/09031936.05.00035205 10.1053/j.seminhematol.2004.07.009 10.1016/j.ymgme.2013.11.012 10.1186/s13023-017-0572-x 10.1007/s00408-016-9893-0 10.1067/mpd.2003.113 10.1097/00005176-199107000-00020 10.1542/peds.2007-3016 10.1016/S1529-1049(02)00049-1 10.3892/ijmm.2016.2835 10.1038/nature13475 10.1038/gim.2015.24 10.1016/j.ymgme.2014.07.005 10.1208/s12248-017-0153-x 10.1016/j.rmr.2017.07.017 10.3899/jrheum.141182
Genetics in Medicine : Official Journal of the American C... Diaz GA, Jones SA et. al.
Apr 21st, 2021 - To assess olipudase alfa enzyme replacement therapy for non-central nervous system manifestations of acid sphingomyelinase deficiency (ASMD) in children. This phase 1/2, international, multicenter, open-label trial (ASCEND-Peds/NCT02292654) admini...
American Journal of Respiratory Cell and Molecular Biology; Poczobutt JM, Mikosz AM et. al.
Mar 5th, 2021 - Deficiency of ASM (acid sphingomyelinase) causes the lysosomal storage Niemann-Pick disease (NPD). Patients with NPD type B may develop progressive interstitial lung disease with frequent respiratory infections. Although several investigations usi...
Feb 25th, 2021 - The phenotype of acid sphingomyelinase deficiency (ASMD) occurs along a continuum. Individuals with the severe early-onset form, infantile neurovisceral ASMD, were historically diagnosed with Niemann-Pick disease type A (NPD-A). The later-onset, c...
Clinicaltrials.gov 3 results
Oct 11th, 2018 - The maximum study duration per patient is approximately 18 months (screening period: up to 60 days; treatment period: 64 weeks; post-treatment period: up to 37 days, not applicable if patient enrolls in a long term extension treatment trial).
Oct 9th, 2018 - The study duration is planned to be 9 years. This study is an extension study for patients who have completed a previous study with olipudase alfa (DFI13803 for pediatric patients and DFI13412 for adult patients).
Mar 19th, 2015 - ASM deficiency (ASMD), also known as Niemann-Pick A and B disease, is a rare genetic disorder in which reduced activity of the lysosomal enzyme, ASM, leads to the accumulation of sphingomyelin primarily in macrophages throughout the body. This def...
News 1 results
Jun 4th, 2015 - PARIS (Reuters) - Sanofi and its subsidiary Genzyme said on Thursday that the U.S. Food and Drug Administration (FDA) has granted breakthrough therapy designation to olipudase alfa. This enzyme replacement therapy is being investigated for the tre...